Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPMATINIB vs CAPREOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPMATINIB vs CAPREOMYCIN: Safety Overview

Metric CAPMATINIB CAPREOMYCIN
Total FAERS Reports 2,301 398
Deaths Reported 583 107
Death Rate 25.3% 26.9%
Hospitalizations 388 148
Average Patient Age 71.9 yrs 36.1 yrs
% Female Patients 53.9% 49.5%
FDA Approval Date May 6, 2020 Approved Prior to Jan 1, 1982
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route ORAL N/A
Marketing Status Prescription Discontinued